Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-07

Clinical Trial Update: PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding [Phase 4]

View source ↗

Summary

Phase 4 trial comparing PCC versus FFP for post-cardiopulmonary bypass coagulopathy and bleeding; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fresh Frozen Plasma (FFP) (fresh frozen plasma)
  • Prothrombin Complex Concentrates (PCC) (prothrombin complex concentrate)

Snippet

Sponsor: Mayo Clinic | Conditions: Bleeding, Blood Loss, Surgical | Phase 4 | Status: COMPLETED | Results posted: 2022-06-07